With the analysis among 375 patents, we discovered top 94 key players by total patent application. BioMarin Pharmaceutical, Inc., PTC Therapeutics MP Inc, Shanghai Biowindow Gene Development Co. Ltd. are dominant in this area. They take 27.20% of the total patent filing.
California, United States
Patent: 43
Shanghai Shi, China
Patent: 20
Bayern, Germany
Patent: 16
New Jersey, United States
Patent: 13
New York, United States
Patent: 12
Tokyo-to, Japan
Patent: 11
Schaffhausen, Switzerland
Patent: 10
Uri, Switzerland
Patent: 10
With the analysis among 8 patents, we discovered top 2 start-ups by total patent application.
Massachusetts, United States
Patent: 3
With the analysis among related 104 patents applied in the last 5 years. We discover 45 most active companies in this area. The fast-growing PTC Therapeutics MP Inc, Virginia Commonwealth University, Shanghai Zhongqiang Pharmaceutical Co., Ltd. take 50.00% of patent filing during this period.
Virginia, United States
Patent: 9
Shanghai Shi, China
Patent: 8
Massachusetts, United States
Patent: 3
Jiangsu Sheng, China
Patent: 2
Jiangsu Sheng, China
Patent: 2
With the analysis among related 104 patents in last 5 years, we discover 37 new entrants. Virginia Commonwealth University, Shanghai Zhongqiang Pharmaceutical Co., Ltd., Sorbonne Université are the most active new entrants in this area.
Virginia, United States
Patent: 9
Shanghai Shi, China
Patent: 8
Massachusetts, United States
Patent: 3
Jiangsu Sheng, China
Patent: 2
Jiangsu Sheng, China
Patent: 2
undefined undefined
Patent: 2
With the analysis among 72 patents, we discovered top 25 universities and scientific research institutions by total patent application. Virginia Commonwealth University, Duquesne University of The Holy Spirit, Sorbonne Université are dominant in this area. They take 29.17% of the total patent filing.
Virginia, United States
Patent: 9
Pennsylvania, United States
Patent: 5
Hovedstaden, Denmark
Patent: 3
Shanghai Shi, China
Patent: 3
Jiangsu Sheng, China
Patent: 3
Zuid-Holland, Netherlands
Patent: 2